Status:
UNKNOWN
Effect of Vitamin D Administration Along With SSRIs in Patients With Major Depressive Disorder
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Conditions:
MDD
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Several studies suggested low serum levels of vitamin D have been associated with depression. So, the present study is designed to investigate the effect of vitamin D administration along with SSRIs i...
Detailed Description
Depression is a major global health problem. Major depression was ranked as the third leading cause of the global burden of diseases in 2004 and is supposed to occupy the first place by 2030. Major de...
Eligibility Criteria
Inclusion
- patients with MDD
- patients with PHQ - 9 score more than 10
- serum vitamin D less than 30 ng/ml
- Serum calcium level 8.5-10.5 mg/dl
Exclusion
- Patients receiving antidepressant and dietary supplement with in last two months.
- Patients with other psychological disorder ( such as schizophrenia, bipolar affective disorder)
- Patients with parathyroid disease, thyroid disease, liver and kidney disease
- Patients with Diabetes mellitus
Key Trial Info
Start Date :
March 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03754712
Start Date
March 10 2018
End Date
February 28 2019
Last Update
November 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BSMMU
Dhaka, Bangladesh